رجوع
نطاق اليوم
KWD 80.60
KWD 82.33
نطاق 52 أسبوعًا
KWD 65.94
KWD 87.89
حجم التداول
3,018,814
متوسط 50 يوم / 200 يوم
KWD 82.43
/
KWD 80.42
الإغلاق السابق
KWD 82.02
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 44.2 | 0.3 |
| P/B | 4.6 | 2.9 |
| ROE % | 10.6 | 3.7 |
| Net Margin % | 17.7 | 3.8 |
| Rev Growth 5Y % | 3.8 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 96.380
+18.0%
Low: KWD 87.000
High: KWD 110.000
مكرر الربحية المستقبلي
27.6
ربحية السهم المستقبلية
KWD 2.968
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
6.7 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 4.557
KWD 4.468 – KWD 4.633
|
9.7 B | 2 |
| FY2029 |
KWD 4.201
KWD 4.119 – KWD 4.271
|
8.9 B | 2 |
| FY2028 |
KWD 3.728
KWD 3.545 – KWD 3.919
|
8.1 B | 4 |
النقاط الرئيسية
Revenue grew 3.77% annually over 5 years — modest growth
Earnings declined -74.28% over the past year
ROE of 10.56% — decent returns on equity
Net margin of 17.69% shows strong profitability
Debt/Equity of 0.07 — conservative balance sheet
Generating 1.34B in free cash flow
النمو
Revenue Growth (5Y)
3.77%
Revenue (1Y)11.55%
Earnings (1Y)-74.28%
FCF Growth (3Y)45.63%
الجودة
Return on Equity
10.56%
ROIC11.11%
Net Margin17.69%
Op. Margin26.97%
الأمان
Debt / Equity
0.07
Current Ratio3.72
Interest Coverage0.00
التقييم
P/E Ratio
44.20
P/B Ratio4.59
EV/EBITDA27.63
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.55% | Revenue Growth (3Y) | 10.05% |
| Earnings Growth (1Y) | -74.28% | Earnings Growth (3Y) | -12.51% |
| Revenue Growth (5Y) | 3.77% | Earnings Growth (5Y) | -8.07% |
| Profitability | |||
| Revenue (TTM) | 6.07B | Net Income (TTM) | 1.07B |
| ROE | 10.56% | ROA | 7.84% |
| Gross Margin | 78.13% | Operating Margin | 26.97% |
| Net Margin | 17.69% | Free Cash Flow (TTM) | 1.34B |
| ROIC | 11.11% | FCF Growth (3Y) | 45.63% |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 3.72 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 44.20 | P/B Ratio | 4.59 |
| P/S Ratio | 7.82 | PEG Ratio | -0.63 |
| EV/EBITDA | 27.63 | Dividend Yield | 0.00% |
| Market Cap | 47.45B | Enterprise Value | 45.21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.07B | 5.44B | 5.01B | 5.38B | 5.23B |
| Net Income | 1.07B | 4.17B | 1.40B | 1.52B | 1.50B |
| EPS (Diluted) | 1.83 | 6.97 | 2.30 | 2.44 | 2.38 |
| Gross Profit | 4.74B | 4.32B | 3.97B | 4.22B | 4.01B |
| Operating Income | 1.64B | 1.38B | 1.43B | 1.70B | 1.61B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13.70B | 13.06B | 9.36B | 8.29B | 8.50B |
| Total Liabilities | 3.36B | 2.99B | 2.64B | 2.49B | 2.67B |
| Shareholders' Equity | 10.34B | 10.00B | 6.65B | 5.81B | 5.84B |
| Total Debt | 705.40M | 700.00M | 685.10M | 691.30M | 690.30M |
| Cash & Equivalents | 2.94B | 3.05B | 1.13B | 769.00M | 862.80M |
| Current Assets | 6.74B | 6.29B | 4.04B | 3.10B | 3.18B |
| Current Liabilities | 1.81B | 1.51B | 1.20B | 1.02B | 1.03B |